Aimei Health Technology Co., Ltd (AFJK) vs Rising Dragon Acquisition Corp. (RDAC)
A side-by-side comparison of Aimei Health Technology Co., Ltd and Rising Dragon Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AFJK
Aimei Health Technology Co., Ltd
$12.11Financial ServicesDelayed quote: Oct 6, 2026, 3:52 PM EDT
RDAC
Rising Dragon Acquisition Corp.
$5.57Financial ServicesDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AFJK vs RDAC
growth of $100 · dividends reinvested · last 2yAFJK +16.5% (+7.9%/yr)RDAC -44.7% (-25.7%/yr)AFJK compounded faster over this window
AFJK RDAC
AFJK vs RDAC: by the numbers
- •AFJK is the larger company ($38M vs $33M market cap).
- •RDAC trades at the lower trailing earnings multiple (30.01 vs 177.57 P/E), one valuation lens rather than an overall verdict.
Metrics side by side
Valuation
| Metric | AFJK | RDAC |
|---|---|---|
| P/E ratio | 177.57 | 30.01 |
| P/B ratio | 4.79 | 2.18 |
Profitability
| Metric | AFJK | RDAC |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 5.15% | 6.71% |
| ROIC | -5.83% | -3.85% |
Frequently asked
- Which has the lower trailing P/E, AFJK or RDAC?
- RDAC has the lower trailing P/E: AFJK trades at 177.57 and RDAC at 30.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
Go deeper
Dig into the metrics
Aimei Health Technology P/E ratioRising Dragon Acquisition P/E ratioAimei Health Technology ROERising Dragon Acquisition ROEAimei Health Technology operating marginRising Dragon Acquisition operating marginAimei Health Technology revenue growthRising Dragon Acquisition revenue growthAimei Health Technology free cash flowRising Dragon Acquisition free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.